Cytocheck Laboratory Revenue and Competitors

Parsons, KS USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Cytocheck Laboratory's estimated annual revenue is currently $7.3M per year.(i)
  • Cytocheck Laboratory's estimated revenue per employee is $216,000

Employee Data

  • Cytocheck Laboratory has 34 Employees.(i)
  • Cytocheck Laboratory grew their employee count by 10% last year.

Cytocheck Laboratory's People

NameTitleEmail/Phone
1
Operations Manager, Quality Control Coordinator, IT Associate, Privacy & Compliance OfficerReveal Email/Phone
2
IT DirectorReveal Email/Phone
3
General ManagerReveal Email/Phone
4
CytotechnologistReveal Email/Phone
5
IT TechnicianReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$427.1M11306%N/AN/A
#2
$13.4M5510%N/AN/A
#3
$23.2M862%N/AN/A
#4
$124.9M3708%N/AN/A
#5
$13.4M55N/AN/AN/A
#6
$54.4M18329%N/AN/A
#7
$189M5606%N/AN/A
#8
$4.9M26-4%N/AN/A
#9
$8.9M41-15%N/AN/A
#10
$4.7M250%N/AN/A
Add Company

What Is Cytocheck Laboratory?

Cytocheck Laboratory, LLC is an independently owned and pathologist operated cytology and anatomical pathology laboratory. We provide pathology services to doctors' offices, health departments, family planning clinics, and hospitals throughout the United States. We offer a variety of services including Pap smear screening, molecular pathology, body fluids, tissue pathology, and more. Most testing results are provided within 24 hours. As an independently owned and pathologist directed laboratory, we are flexible enough to serve your needs and requirements while maintaining an exceedingly high quality. As opposed to you having to integrate into our laboratory's operations, we are designed to customize our process to fit your needs.

keywords:N/A

N/A

Total Funding

34

Number of Employees

$7.3M

Revenue (est)

10%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.3M3413%N/A
#2
$6.3M4442%N/A
#3
N/A53130%N/A
#4
$10.6M5617%N/A
#5
$7.5M635%N/A